For Campenaerts, the illness narrative has grown larger than the reality inside the Visma camp. “A lot was said about being ill, but I would rather describe it as a glorified cold,”
Campenaerts told Sporza. “It was a cold that was going around the whole peloton. There was never a moment when Jonas was in trouble.”
Visma keep focus despite commanding lead
The comments come after Visma had previously confirmed Vingegaard was among those affected by the illness symptoms that had circulated during the race.
Sports director Jesper Morkov had earlier said the team had dealt with “a bit of coughing and tickling in the throat among some of the boys”,
before confirming of Vingegaard: “He has also been one of them, but everything seems to be fine.”
Since then, the balance of the Giro has changed completely. Any suggestion that Vingegaard might be vulnerable has been replaced by the reality of a rider who has strengthened his grip on the maglia rosa and repeatedly distanced his GC rivals in the mountains.
Still, Campenaerts made clear that Visma are not treating the final days as a procession. “It stays serious,” he said. “We drink a glass of champagne, but we cannot celebrate it like Alberto Bettiol celebrated his victory.”
Bettiol’s stage 13 win gave XDS Astana another major success at this Giro, but Visma’s situation is different. Their target is the overall title, and with the decisive mountain stages still to come, Campenaerts stressed that the team remain fully locked in. “We are putting absolutely everything into winning,” he said. “It is no secret that Friday and Saturday are the important stages.”
Jonas Vingegaard at the 2026 Giro d'Italia
Vingegaard illness question fades after mountain dominance
The illness story mattered because of its timing. In the opening week, Vingegaard had not looked in trouble, but nor had he yet turned the Giro into the controlled race it has since become. Once Visma confirmed he had been affected, it gave rivals and observers a possible explanation for why the race had not already been blown apart.
That window now looks to have closed. Vingegaard’s performances since then have shifted the illness discussion from a live weakness to a resolved subplot. His victory in pink on stage 16 to Cari was the clearest sign yet that the Dane had moved beyond any early race concern. Stage 17 then passed without drama for the maglia rosa, as Michael Valgren won from the breakaway and Visma kept the overall race under control behind.
Campenaerts’ comments do not deny that Vingegaard was affected. They reframe the scale of the problem. Illness did pass through the peloton, and Vingegaard was among those who felt it, but Visma’s message is now clear: it never reached the point where their leader’s Giro challenge was truly under threat.
With two major mountain days still standing between Vingegaard and Rome, that distinction matters. The scare may have added intrigue to the second week, but the race now belongs to a rider whose team insists he was never as vulnerable as the outside noise suggested.